# Tempus AI, Inc.: filings TEM · Nasdaq · CIK 1717115 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/tem.md) · [Financials](/companies/tem/financials.md) · [Filings](/companies/tem/filings.md) · [Insiders](/companies/tem/insiders.md) ## Reports and events: 40 filings Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 213, 144 136, 8-K 25, 3 17, DRSLTR 11, UPLOAD 11, DRS/A 10, SCHEDULE 13G/A 10, 10-Q 7, 424B3 4, D 4, SCHEDULE 13G 4, CORRESP 3, EFFECT 3, S-8 3, SC 13G 3, 10-K 2, 4/A 2, ARS 2, DEF 14A 2, DEFA14A 2, S-1 2, S-1/A 2, S-4/A 2, S-8 POS 2, 424B4 1, 424B7 1, 425 1, 8-A12B 1, CERT 1, DEF 14C 1, DRS 1, PRE 14A 1, PRE 14C 1, S-3ASR 1, S-4 1). | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-10-23 | 09:00 ET | [8-K](/filings/0001193125-26-429533.md) | 8.01 Other events | 0001193125-26-429533 | | 2026-07-30 | 16:03 ET | [10-Q](/filings/0001193125-26-326090.md) | Quarterly report, period 2026-06-30 | 0001193125-26-326090 | | 2026-07-30 | 16:01 ET | [8-K](/filings/0001193125-26-326083.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-326083 | | 2026-07-20 | 17:15 ET | [8-K](/filings/0001193125-26-309073.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-26-309073 | | 2026-07-20 | 09:03 ET | [8-K](/filings/0001193125-26-308469.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-308469 | | 2026-05-22 | 16:01 ET | [8-K](/filings/0001193125-26-236814.md) | 5.07 Shareholder vote results | 0001193125-26-236814 | | 2026-05-13 | 19:18 ET | [8-K](/filings/0001193125-26-220115.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-220115 | | 2026-05-05 | 16:05 ET | [10-Q](/filings/0001193125-26-206356.md) | Quarterly report, period 2026-03-31 | 0001193125-26-206356 | | 2026-05-05 | 16:02 ET | [8-K](/filings/0001193125-26-206317.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-206317 | | 2026-04-07 | 16:06 ET | [DEF 14A](/filings/0001193125-26-145528.md) | Proxy statement, period 2026-05-21 | 0001193125-26-145528 | | 2026-02-24 | 16:06 ET | [10-K](/filings/0001193125-26-066961.md) | Annual report, period 2025-12-31 | 0001193125-26-066961 | | 2026-02-24 | 16:01 ET | [8-K](/filings/0001193125-26-066931.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-066931 | | 2026-01-12 | 06:05 ET | [8-K](/filings/0001193125-26-009650.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-009650 | | 2025-11-04 | 16:06 ET | [10-Q](/filings/0001193125-25-264652.md) | Quarterly report, period 2025-09-30 | 0001193125-25-264652 | | 2025-11-04 | 16:01 ET | [8-K](/filings/0001193125-25-264616.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-264616 | | 2025-08-27 | 17:11 ET | [8-K](/filings/0001193125-25-189857.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-189857 | | 2025-08-08 | 06:06 ET | [10-Q](/filings/0000950170-25-105449.md) | Quarterly report, period 2025-06-30 | 0000950170-25-105449 | | 2025-08-08 | 06:04 ET | [8-K](/filings/0000950170-25-105441.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-105441 | | 2025-07-03 | 17:21 ET | [8-K](/filings/0001193125-25-155545.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-155545 | | 2025-05-23 | 06:31 ET | [8-K](/filings/0001193125-25-125425.md) | 5.07 Shareholder vote results | 0001193125-25-125425 | | 2025-05-06 | 16:07 ET | [10-Q](/filings/0000950170-25-064447.md) | Quarterly report, period 2025-03-31 | 0000950170-25-064447 | | 2025-05-06 | 16:02 ET | [8-K](/filings/0000950170-25-064419.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-064419 | | 2025-04-23 | 08:09 ET | [8-K](/filings/0001193125-25-090062.md) | 8.01 Other events | 0001193125-25-090062 | | 2025-04-07 | 16:06 ET | [DEF 14A](/filings/0001193125-25-074642.md) | Proxy statement, period 2025-05-20 | 0001193125-25-074642 | | 2025-02-25 | 09:04 ET | [S-1](/filings/0001193125-25-034442.md) | Registration statement | 0001193125-25-034442 | | 2025-02-24 | 16:05 ET | [10-K](/filings/0000950170-25-025603.md) | Annual report, period 2024-12-31 | 0000950170-25-025603 | | 2025-02-24 | 16:02 ET | [8-K](/filings/0000950170-25-025587.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-025587 | | 2025-02-03 | 16:36 ET | [8-K](/filings/0001193125-25-019313.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-25-019313 | | 2025-01-13 | 08:44 ET | [8-K](/filings/0001193125-25-005041.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-005041 | | 2024-11-05 | 16:05 ET | [8-K](/filings/0001193125-24-251239.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001193125-24-251239 | | 2024-11-04 | 16:05 ET | [10-Q](/filings/0000950170-24-120677.md) | Quarterly report, period 2024-09-30 | 0000950170-24-120677 | | 2024-11-04 | 16:02 ET | [8-K](/filings/0000950170-24-120663.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-120663 | | 2024-09-06 | 16:06 ET | [8-K](/filings/0001193125-24-215157.md) | 8.01 Other events | 0001193125-24-215157 | | 2024-08-20 | 16:26 ET | [8-K](/filings/0001493152-24-033274.md) | 8.01 Other events | 0001493152-24-033274 | | 2024-08-06 | 16:05 ET | [10-Q](/filings/0001193125-24-194869.md) | Quarterly report, period 2024-06-30 | 0001193125-24-194869 | | 2024-08-06 | 16:02 ET | [8-K](/filings/0001193125-24-194863.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-194863 | | 2024-06-17 | 16:05 ET | [8-K](/filings/0001193125-24-162594.md) | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001193125-24-162594 | | 2024-06-13 | 06:26 ET | [S-1/A](/filings/0001193125-24-160268.md) | Registration statement, amended | 0001193125-24-160268 | | 2024-06-05 | 06:04 ET | [S-1/A](/filings/0001193125-24-154635.md) | Registration statement, amended | 0001193125-24-154635 | | 2024-05-20 | 17:04 ET | [S-1](/filings/0001193125-24-142956.md) | Registration statement | 0001193125-24-142956 | Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 29, 2026, 16:16 ET. No prices; not investment advice.